Clover Health Investments

Clover Health Investments
Clover Health Investments
CLOV
NASDAQ
3.65 USD
1.11%

About

Clover Health Investments, Corp. is a physician enablement company. The Company is focused on seniors who have historically lacked access to affordable healthcare. It offers a software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes.

The Company operates under two segments: Insurance and Non-Insurance. Through its Insurance segment, it provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. The Company's Non-Insurance segment consists of operations in connection with its participation in the Direct Contracting program.

The Company’s subsidiaries include Clover Health Labs, LLC, Medical Service Professionals of NJ LLC, Clover HMO of New Jersey Inc., Clover Health Holdings, Inc. and Clover Health Partners, LLC..

Financials Amount (in millions)

Income statement
Balance sheet
Cash flow

Ratios

Price and Volume
Volume
Ten Day Average Volume 14.9M
Three Month Average Volume 150.3M
High Low
Fifty-Two Week High 3.815 USD
Fifty-Two Week Low 0.606 USD
Fifty-Two Week High Date 22 Aug 2024
Fifty-Two Week Low Date 22 Apr 2024
Price and Volume
Current Price 2.63 USD
Beta 2
Relative Price Change
Four Week Relative Price Change 49.07%
Thirteen Week Relative Price Change 123.39%
Twenty-Six Week Relative Price Change 176.46%
Fifty-Two Week Relative Price Change 60.22%
Year-to-Date Relative Price Change 133.27%
Price Change
One Day Price Change -6.74%
Thirteen Week Price Change 139.09%
Twenty-Six Week Price Change 203.98%
Five Day Price Change -21.26%
Fifty-Two Week Price Change 100.76%
Year-to-Date Price Change 176.23%
Month-to-Date Price Change 37.70%
Per Share Data
Book Value
Book Value Per Share (Last Fiscal Year) 0.58561 USD
Book Value Per Share (Most Recent Quarter) 0.67466 USD
Tangible Book Value Per Share (Last Fiscal Year) 0.5795 USD
Tangible Book Value Per Share (Most Recent Quarter) 0.66845 USD
EBITD
EBITD Per Share (Trailing Twelve Months) -0.20659 USD
Revenue
Revenue Per Share (Last Fiscal Year) 4.21779 USD
Revenue Per Share (Trailing Twelve Months) 3.48104 USD
Dividend
Dividend Per Share (Last Fiscal Year) -99999.99 USD
Dividend Per Share (Trailing Twelve Months) 0 USD
Dividend Per Share (5 Year) -99999.99 USD
Earnings Per Share
Excluding Extraordinary Items (Last Fiscal Year) -0.4425 USD
Excluding Extraordinary Items (Trailing Twelve Months) -0.26444 USD
Normalized (Last Fiscal Year) -0.38883 USD
Basic Excluding Extraordinary Items (Last Fiscal Year) -0.4425 USD
Basic Excluding Extraordinary Items (Trailing Twelve Months) -0.26421 USD
Including Extraordinary Items (Last Fiscal Year) -0.4425 USD
Including Extraordinary Items (Trailing Twelve Months) -0.25573 USD
Cash
Cash Per Share (Last Fiscal Year) 0.60999 USD
Cash Per Share (Most Recent Quarter) 0.78826 USD
Cash Flow Per Share (Last Fiscal Year) -0.4371 USD
Cash Flow Per Share (Trailing Twelve Months) -0.25882 USD
Free Cash Flow Per Share (Trailing Twelve Months) -0.36587 USD
Margins
Cash Flow Revenue
Cash Flow Revenue (5 Year) -100,000
Cash Flow Revenue (Trailing Twelve Months) -11
Pretax Margin
Pretax Margin (Trailing Twelve Months) -7.55%
Pretax Margin (Last Fiscal Year) -10.49%
Pretax Margin (5 Year) -99,999.99%
Gross Margin
Gross Margin (Last Fiscal Year) -99,999.99%
Gross Margin (Trailing Twelve Months) -99,999.99%
Gross Margin (5 Year) -99,999.99%
Operating Margin
Operating Margin (Last Fiscal Year) -10.25%
Operating Margin (Trailing Twelve Months) -7.23%
Operating Margin (5 Year) -99,999.99%
Net Profit Margin
Net Profit Margin (Last Fiscal Year) -10.49%
Net Profit Margin (Trailing Twelve Months) -7.55%
Net Profit Margin (5 Year) -99,999.99%
Growth
Book Value
Book Value Per Share (5 Year) -99,999.99%
Tangible Book Value (5 Year) -99,999.99%
Free Operating Cash Flow
Free Operating Cash Flow (5 Year) -99,999.99%
Revenue
Revenue Change MRQ vs 1 Year Ago 11.28%
Revenue Growth (3 Year) -99,999.99%
Revenue Change (Trailing Twelve Months) -29.29%
Revenue Per Share Growth -99,999.99%
Revenue Growth (5 Year) -99,999.99%
Capital Spending Debt
Capital Spending (5 Year) -99,999.99%
Total Debt (5 Year) -99,999.99%
Dividends
Dividend Growth (3 Year) -99,999.99%
Earnings Per Share
EPS Change MRQ vs 1 Year Ago 124.02%
EPS Change (Trailing Twelve Months) 52.79%
EPS Growth (3 Year) -99,999.99%
EPS Growth (5 Year) -99,999.99%
EBITDA
EBITDA (5 Year) -99,999.99%
EBITDA (5 Year Interim) -99,999.99%
Net Profit Margin
Net Profit Margin Growth (5 Year) -99,999.99%
Valuation
Total Price to Book
Price to Tangible Book (Last Fiscal Year) 5
Price to Tangible Book (Most Recent Quarter) 4
Price to Free Cash Flow
Price to Free Cash Per Share (Last Fiscal Year) -100,000
Price to Free Cash Per Share (Trailing Twelve Months) -100,000
Net Debt
Net Debt (Most Recent Quarter) -379,594,000
Net Debt (Last Fiscal Year) -298,316,000
Price to Sales
Price to Sales (Last Fiscal Year) 1
Price to Sales (Trailing Twelve Months) 1
Price to Earnings
PE Excluding Extraordinary Items (Last Fiscal Year) -100,000
PE Normalized (Last Fiscal Year) -100,000
PE Basic Excluding Extraordinary Items (Trailing Twelve Months) -100,000
PE Excluding Extraordinary Items High (Trailing Twelve Months) -100,000
PE Excluding Extraordinary Items Low (Trailing Twelve Months) -100,000
PE Including Extraordinary Items (Trailing Twelve Months) -100,000
Dividends
Dividend Yield (5 Year) -99,999.99%
Dividend Yield -99,999.99%
Current Dividend Yield 0.00%
Price to Book
Price to Book (Last Fiscal Year) 4
Price to Book (Most Recent Quarter) 4
Financial Strength
Debt to Equity
Long Term Debt to Equity (Last Fiscal Year) 0
Long Term Debt to Equity (Most Recent Quarter) 0
Payout Ratio
Payout Ratio (Last Fiscal Year) -99,999.99%
Payout Ratio (Trailing Twelve Months) -99,999.99%
Quick Ratio
Quick Ratio (Last Fiscal Year) -100,000
Quick Ratio (Most Recent Quarter) -100,000
Enterprise Value
Current Enterprise Value to Free Cash Flow (Last Fiscal Year) -100,000
Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) -100,000
Current Ratio
Current Ratio (Last Fiscal Year) 2
Current Ratio (Most Recent Quarter) 2
Free Cash Flow
Free Cash Flow (Last Fiscal Year) -116,455,000
Free Cash Flow (Trailing Twelve Months) -178,205,000
Net Interest Coverage
Net Interest Coverage (Last Fiscal Year) -38
Net Interest Coverage (Trailing Twelve Months) -19
Total Debt to Equity
Total Debt to Equity (Last Fiscal Year) 0
Total Debt to Equity (Most Recent Quarter) 0
Management Effectiveness
Return on Assets
Return on Assets (Last Fiscal Year) -30.94%
Return on Assets (Trailing Twelve Months) -13.24%
Return on Assets (5 Year) -99,999.99%
Return on Equity
Return on Equity (Last Fiscal Year) -66.34%
Return on Equity (Trailing Twelve Months) -39.04%
Return on Equity (5 Year) -99,999.99%
Return on Investment
Return on Investment (Last Fiscal Year) -62.14%
Return on Investment (Trailing Twelve Months) -36.56%
Return on Investment (5 Year) -99,999.99%

Cookie Settings

We use cookies to deliver and improve our services, analyze site usage, and if you agree, to customize or personalize your experience and market our services to you. You can read our Cookie Policy here.